AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Transgene

Capital/Financing Update Jul 10, 2024

1715_rns_2024-07-10_47802d9e-3049-439f-8eee-f093cd536a89.pdf

Capital/Financing Update

Open in Viewer

Opens in native device viewer

PRESS RELEASE

Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of June 30, 2024

Strasbourg, July 10, 2024 – 06:00 pm CET

Under the liquidity contract entrusted by Transgene to Natixis Oddo BHF SCA, as of June 30, 2024, the following resources were managed through the liquidity account:

    1. 338,789 shares
    1. € 94,328.20

In the first half of 2024, it was negotiated a total of:

Purchases 204,900
shares
€ 248,651 894
market transactions
Sales 169,972
shares
€ 217,858 769
market transactions

It is recalled that:

    1. as of December 31, 2023, the following resources were managed through the liquidity account:
    2. 303,861 shares
    3. € 125,121
    1. at the time the liquidity program was transferred to Natixis Oddo BHF SCA on January 2, 2020, the resources managed through the liquidity account consisted of:
    2. 164,183 shares
    3. € 246,158
    1. when the liquidity program was initially established in 2016, the following resources were made available:
    2. € 500,000

Contacts

Transgene: Lucie Larguier Chief Financial Officer +33 (0)3 88 27 91 00 [email protected]

Talk to a Data Expert

Have a question? We'll get back to you promptly.